ISPOR 19th Annual European Congress

Nuestra empresa estará presente en la próxima edición del congreso europeo de la International Society for Pharmacoeconomics and Outcomes Research.

 

Estas son las comunicaciones en las que Outcomes ’10 ha colaborado y que se presentarán en este congreso:

 

  •  AD3 MEDICATION ADHERENCE AND PERSISTANCE IN TYPE 2 DIABETES MELLITUS (T2DM): PATIENTS PERSPECTIVE IN THE SPANISH HEALTH CARE SYSTEM
  •  PHP185 PREFERENCES FOR THE CHARACTERISTICS OF HOME ENTERAL NUTRITION (HEN) VIA TUBE FEEDING: A DISCRETE-CHOICE EXPERIMENT
  •  PMS63 ECONOMIC BURDEN OF ANKYLOSING SPONDYLITIS IN EUROPE. A SYSTEMATIC REVIEW OF THE LITERATURE
  •  PMS71 PATIENT REPORTED OUTCOMES IN SPONDYLOARTHRITIS PATIENTS IN EUROPE: A SYSTEMATIC REVIEW OF THE LITERATURE
  •  PSS32 SOCIAL AND ECONOMIC BURDEN OF SKIN DISEASE IN EUROPE. A NARRATIVE REVIEW OF THE LITERATURE
  •  PSY136 TOO OLD FOR TREATMENT: AGEISM IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL). A NARRATIVE REVIEW OF THE LITERATURE
  •  PCV39 ECONOMIC IMPACT OF RIVAROXABAN USE FOR THROMBOEMBOLIC EVENTS PREVENTION AFTER HIP OR KNEE REPLACEMENT IN SPAIN
  •  PCV40 BUDGET IMPACT ANALYSIS OF THE USE OF RIVAROXABAN IN TREATMENT OF VENOUS THROMBOEMBOLISM IN SPAIN

 

Para saber más sobre el congreso: www.ispor.org/Event/index/2016Vienna

 

Para saber más acerca de las comunicaciones Podium Presentations: http://www.ispor.org/Event/ProgramList/2016Vienna?type=Podium

 

Para saber más acerca de las comunicaciones Poster Presentations: http://www.ispor.org/Event/ProgramList/2016Vienna?type=Poster